IRADIMED Corporation announced a special cash dividend of $0.50 per share of its outstanding common stock.
The dividend is payable on December 30, 2025, to stockholders of record as of December 17, 2025.
The Company is a leader in developing MRI-compatible medical devices and products.
Special Cash Dividend
$0.50 per share, payable on December 30, 2025.
Financial Strength
Cash and cash equivalents balance of $56.5 million at the end of Q3 2025.
Innovative Products
Producer of non-magnetic IV infusion pump and patient vital signs monitoring system for MRI procedures.
- The special dividend underlines the Company's commitment to maximizing returns for stockholders.
- Strong financial performance and cash generation contribute to the decision to distribute excess cash.
- Future growth expected from the commercialization of the next-generation MRI IV pump in 2026 and beyond.
IRADIMED Corporation's strategic decision to issue a special cash dividend reflects its financial strength and dedication to rewarding stockholders. The focus on innovation in MRI-compatible medical devices positions the Company for continued growth in the future.